During the past decade, Fundacion Rosarina de Neurorehabilitacion conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 4 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Fundacion Rosarina de Neurorehabilitacion" #1 sponsor was "Hoffmann-La Roche" with 5 trials, followed by "Alexion" with 2 trials sponsored, "EMD Serono" with 1 trials sponsored, "EMD Serono Research & Development Institute, Inc." with 1 trials sponsored and "Merck KGaA, Darmstadt, Germany" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Fundacion Rosarina de Neurorehabilitacion" #1 collaborator was "Pfizer" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Fundacion Rosarina de Neurorehabilitacion" are "Multiple Sclerosis" (3 trials), "Neuromyelitis Optica" (2 trials), "Neuromyelitis Optica Spectrum Disorder" (2 trials), "Multiple Sclerosis, Primary Progressive" (1 trials) and "Multiple Sclerosis, Relapsing Remitting" (1 trials). Many other conditions were trialed in "Fundacion Rosarina de Neurorehabilitacion" in a lesser frequency.

Most popular intervention types in "Fundacion Rosarina de Neurorehabilitacion" are "Drug" (8 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Ocrelizumab" (5 trials), "Placebo" (2 trials), "Cladribine" (1 trials), "Copaxone®" (1 trials) and "Eculizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Fundacion Rosarina de Neurorehabilitacion" are 10 trials for "All" genders.

Currently, there are NaN active trials in "Fundacion Rosarina de Neurorehabilitacion". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Fundacion Rosarina de Neurorehabilitacion, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Fundacion Rosarina de Neurorehabilitacion, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".